Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Buis DTP, van der Vaart TW, Prins JM, van der Meer JTM, Bonten MJM, Sieswerda E, van Werkhoven CH, Sigaloff KCE. Buis DTP, et al. Among authors: sieswerda e. J Antimicrob Chemother. 2024 Feb 1;79(2):476. doi: 10.1093/jac/dkad385. J Antimicrob Chemother. 2024. PMID: 38078830 Free PMC article. No abstract available.
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment.
Buis D, van Werkhoven CH, van Agtmael MA, Bax HI, Berrevoets M, de Boer M, Bonten M, Bosmans JE, Branger J, Douiyeb S, Gelinck L, Jong E, Lammers A, Van der Meer J, Oosterheert JJ, Sieswerda E, Soetekouw R, Stalenhoef JE, Van der Vaart TW, Bij de Vaate EA, Verkaik NJ, Van Vonderen M, De Vries PJ, Prins JM, Sigaloff K; Collaborators SAFE-trial study group. Buis D, et al. Among authors: sieswerda e. BMJ Open. 2023 Apr 21;13(4):e068295. doi: 10.1136/bmjopen-2022-068295. BMJ Open. 2023. PMID: 37085305 Free PMC article.
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Buis DTP, van der Vaart TW, Prins JM, van der Meer JTM, Bonten MJM, Sieswerda E, van Werkhoven CH, Sigaloff KCE, Herpers BL, Jansen RR, Rozemeijer W, Soetekouw R, van Twillert G, Veenstra J. Buis DTP, et al. Among authors: sieswerda e. J Antimicrob Chemother. 2023 May 3;78(5):1175-1181. doi: 10.1093/jac/dkad057. J Antimicrob Chemother. 2023. PMID: 36897327 Free PMC article.
Overuse and Misuse of Antibiotics and the Clinical Consequence in Necrotizing Pancreatitis: An Observational Multicenter Study.
Timmerhuis HC, van den Berg FF, Noorda PC, van Dijk SM, van Grinsven J, Sperna Weiland CJ, Umans DS, Mohamed YA, Curvers WL, Bouwense SAW, Hadithi M, Inderson A, Issa Y, Jansen JM, de Jonge PJF, Quispel R, Schwartz MP, Stommel MWJ, Tan ACITL, Venneman NG, Besselink MG, Bruno MJ, Bollen TL, Sieswerda E, Verdonk RC, Voermans RP, van Santvoort HC; Dutch Pancreatitis Study Group. Timmerhuis HC, et al. Among authors: sieswerda e. Ann Surg. 2023 Oct 1;278(4):e812-e819. doi: 10.1097/SLA.0000000000005790. Epub 2023 Jan 3. Ann Surg. 2023. PMID: 36728517
INCIDENCE, RISK FACTORS, AND OUTCOME OF SUSPECTED CENTRAL VENOUS CATHETER-RELATED INFECTIONS IN CRITICALLY ILL COVID-19 PATIENTS: A MULTICENTER RETROSPECTIVE COHORT STUDY.
Smit JM, Exterkate L, van Tienhoven AJ, Haaksma ME, Heldeweg MLA, Fleuren L, Thoral P, Dam TA, Heunks LMA, Gommers D, Cremer OL, Bosman RJ, Rigter S, Wils EJ, Frenzel T, Vlaar AP, Dongelmans DA, de Jong R, Peters M, Kamps MJA, Ramnarain D, Nowitzky R, Nooteboom FGCA, de Ruijter W, Urlings-Strop LC, Smit EGM, Mehagnoul-Schipper DJ, Dormans T, de Jager CPC, Hendriks SHA, Achterberg S, Oostdijk E, Reidinga AC, Festen-Spanjer B, Brunnekreef GB, Cornet AD, van den Tempel W, Boelens AD, Koetsier P, Lens J, Faber HJ, Karakus A, Entjes R, de Jong P, Rettig TCD, Arbous S, Vonk B, Machado T, Girbes ARJ, Sieswerda E, Elbers PWG, Tuinman PR. Smit JM, et al. Among authors: sieswerda e. Shock. 2022 Nov 1;58(5):358-365. doi: 10.1097/SHK.0000000000001994. Epub 2022 Sep 8. Shock. 2022. PMID: 36155964
The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults.
Sieswerda E, Bax HI, Hoogerwerf JJ, de Boer MGJ, Boermeester M, Bonten MJM, Dekker D, van Wijk RG, Juffermans NP, Kuindersma M, van der Linden PD, Melles DC, Pickkers P, Schouten JA, Rebel JR, van Zanten ARH, Prins JM, Wiersinga WJ. Sieswerda E, et al. BMC Infect Dis. 2022 Aug 11;22(1):687. doi: 10.1186/s12879-022-07653-3. BMC Infect Dis. 2022. PMID: 35953772 Free PMC article.
[18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review.
Buis DTP, Sieswerda E, Kouijzer IJE, Huynh WY, Burchell GL, Berrevoets MAH, Prins JM, Sigaloff KCE. Buis DTP, et al. Among authors: sieswerda e. BMC Infect Dis. 2022 Mar 24;22(1):282. doi: 10.1186/s12879-022-07273-x. BMC Infect Dis. 2022. PMID: 35331165 Free PMC article.
Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S, de la Court JR, Buis DTP, Meijboom LJ, Schade RP, Visser CE, van Hest R, Kuijvenhoven M, Prins JM, Nijman SFM, Sieswerda E, Sigaloff KCE. Coenen S, et al. Among authors: sieswerda e. Antimicrob Resist Infect Control. 2021 Oct 30;10(1):155. doi: 10.1186/s13756-021-01024-4. Antimicrob Resist Infect Control. 2021. PMID: 34717761 Free PMC article.
32 results